In prostate cancer, NIBAN1 is rapidly activated in response to ER stress by ATF4, either by stimulating eIF2α phosphorylation, via PERK, or by inhibiting eIF2α phosphorylation directly, via NIBAN1 (Figure 2A). Here, EIF2A is linked to prostate cancer.